Portfolio News

Pittsburgh-based company behind ‘promising’ new COVID-19 treatment

On Wednesday, the Wolf Administration plans to highlight what it calls in a news advisory a “promising new drug candidate to treat COVID-19.” The Department of Community and Economic Development will announce that Pittsburgh-based biotechnology company CytoAgents has begun its Phase 1 clinical trial for COVID-19 treatment. Read more >>
Read more...

All-Star Athletes Across Sports Are Seeing Injury Recovery Without Surgery or Medication Using SAM 2.0 Wearable Ultrasound

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device supported by the National Institutes of Health, announces that the SAM family of medical ultrasound device has received positive reviews and feedback from professional athletes across a number of different sports and disciplines. The medical device's ability to provide relief from muscle injury and pain showcases SAM's ability to deal with the physical rigors of professional sports and is perfect for home use...
Read more...

ClassLink and Scrible Partnership Demonstrates the Benefits of Integrated Technology for School Districts

As easy access to digital resources grows increasingly critical to learning, the new ClassLink and Scrible partnership demonstrates how interoperability and open standards support remote and hybrid learning. ClassLink, the leading single sign-on platform for education, and Scrible, an advanced research and writing platform, now integrate using open standards. Read more >>
Read more...

How CytoAgents’ plans for growth run far beyond Covid crisis

GP1681 “has the potential to be the next best practice in medicine in areas with significant unmet need,” CytoAgents CEO Teresa Whalen said. Out clinical trials as well as plans for growth to include other uses for the dreuge. CytoAgents is working in Australia with its partner, Novotech, on the phase one clinical trial of GP1681...Read more >>
Read more...

Emovi, Inc. Announces Partnership with Sports Illustrated as Key Sponsor for The Sports Illustrated Awards

Emovi, Inc., a global medical device developer, today announced a partnership with Sports Illustrated as a sponsor of the 2020 Sports Illustrated Awards (SI Awards). The SI Awards will take place in Las Vegas on December 19. Viewers can stream the primetime broadcast live via the Sports Illustrated Facebook page beginning at 7:00 PM ET.Read more >>
Read more...

Wasabi Named an Outperformer in GigaOm Radar for Alternatives to Amazon AWS S3

Wasabi, the hot cloud storage company, has been named an “outperformer” in the new report, “GigaOm Radar for Alternatives to Amazon AWS S3.” GigaOm evaluated 11 cloud storage vendors based on common metrics related to Amazon AWS S3 including cost-predictability, performance, multi-cloud environment, and lock-in avoidance. Vendors were then categorized by execution, roadmap, and ability to innovate. Read more >>
Read more...

From Conquering COVID-19 to Curing Cancer, New York City Charts the Future of Life Sciences

For the past 25 years, the public and private sectors have worked together to establish New York City as a global leader in life sciences research and innovation. Thanks to that coordinated effort, the city was able to respond to COVID-19 efficiently and effectively, becoming a model for other urban areas as COVID-19 cases peaked across the U.S.—and showcasing a burgeoning life sciences industry in the city that’s poised for future growth... New York life sciences companies continue to step...
Read more...

Growing natural food companies keep Boulder on the map

1908 Brands product development specialist Sherri Smith inspects products being put through a low-temperature stability test, to ensure that the product is stable when going through temperature cycles, last month in Boulder. The company is one of several Boulder-based natural brands that are following in the footsteps of the industry’s early pioneers. Read more >>
Read more...